Tate & Lyle PLC
Tate & Lyle PLC - 15 June 2007
Tate & Lyle announces completion of investment in G.C Hahn & Co.
Tate & Lyle, the global renewable ingredients company, is pleased to announce
that it has today completed the acquisition of an 80% holding in German
specialty food ingredients group G. C. Hahn & Co ('Hahn') for a total cash
consideration of £78 million (EUR 116 million). This follows the initial
announcement of 16 April 2007.
Notes to Editors
Hahn is privately owned and was founded in 1848. Its headquarters and primary
operations are located in Lübeck, Germany. It also has production operations in
the UK, USA and Australia, and sales offices in 22 countries. Hahn is a
recognised leader in dairy stabiliser systems and works closely with customers
across the world to develop customised ingredient solutions.
-0-
*T
For more information contact:
Mark Robinson
Director of Investor Relations
t:+442079776189
m:+447793515861
e: mark.robinson@tateandlyle.com
Ferne Hudson
Head of Media & Public Relations
t:+44(0)20 7977 6143
m:+44(0)7713 067 433
f:+44(0)20 7623 5213
e: ferne.hudson@tateandlyle.com
*T
About Tate & Lyle
Tate & Lyle is a world leading manufacturer of renewable food and industrial
ingredients. It uses innovative technology to transform corn, wheat and sugar
into value-added ingredients for customers in the food, beverage,
pharmaceutical, cosmetic, paper, packaging and building industries. The Company
is a leader in cereal sweeteners and starches, sugar refining, value added food
and industrial ingredients, and citric acid. Tate & Lyle is the world number-one
in industrial starches and is the sole manufacturer of SPLENDA(R) Sucralose.
Headquartered in London, Tate & Lyle is listed on the London Stock Exchange
under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company
operates more than 60 production facilities in 24 countries, throughout Europe,
the Americas and South East Asia. It employs 6,900 people in its subsidiaries
with a further 2,300 employed in joint ventures. Sales in the year to 31 March
2007 totalled £4.0 billion. Additional information can be found on
http://www.tateandlyle.com.
SPLENDA(R) is a trademark of McNeil Nutritionals, LLC
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.